Skip to main content
SpringerLink
Log in

Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

The selective serotonin uptake inhibitor fluoxetine (10mg/kg i.p.) increased tissue levels of the norepinephrine metabolite 3-methoxy-4-hydroxyphenylethylene glycol sulfate (MHPG-SO4) in rat hypothalamus, indicating an increased release of norepinephrine. Microdialysis studies in conscious rats showed that fluoxetine (10 mg/kg i.p.) increased extracellular concentrations of norepinephrine as well as serotonin in the hypothalamus. In contrast, desipramine (10mg/kg i.p.) increased extracellular concentration of norepinephrine but not serotonin in the hypothalamus. Consistent with its mechanism of being a selective serotonin uptake inhibitor, local perfusion of fluoxetine (10μM) caused a 7-fold increase in hypothalamic extracellular serotonin and a small non-significant increase in extracellular norepinephrine. The subsequent systemic injection of fluoxetine (10mg/kg s.c.) after local perfusion caused a 3-fold increase in extracellular norepinephrine, indicating that fluoxetine's action leading to an increase in extracellular norepinephrine was not occurring in the terminal areas of the hypothalamus but elsewhere in the brain, possibly cell bodies in the locus coeruleus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bareggi SR, Markey K, Genovese E (1978) Effects of single and multiple doses of desipramine on endogenous levels of 3-methyoxy-4-hydroxyphenylglycol-sulfate (MOPEG-SO4) in rat brain. Eur J Pharmacol 50: 301–306

    PubMed  Google Scholar 

  • Blandina P, Goldfarb J, Walcott J, Green JP (1991) Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices. J Pharmacol Exp Ther 256: 341–347

    PubMed  Google Scholar 

  • Calderini G, Morselli PL, Garattini S (1975) Effect of amphetamine and fenfluramine on brain noradrenaline and MOPEG-SO4. Eur J Pharmacol 34: 345–350

    PubMed  Google Scholar 

  • Cedarbaum JM, Aghajanian GK (1978) Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J Comp Neurol 178: 1–16

    PubMed  Google Scholar 

  • Chen NH, Reith MEA (1995) Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-proplyamino)tetralin. J Neurochem 64: 1585–1597

    PubMed  Google Scholar 

  • Clement HW, Gemsa D, Wesmann W (1992) Serotonin-norepinephrine interactions: a voltammetric study on the effect of serotonin receptor stimulation followed in the N raphe dorsalis and the locus coeruleus of the rat. J Neural Transm [GenSect] 88: 11–23

    Google Scholar 

  • Crawley JN, Mass JW, Roth RH (1980) Biochemical evidence for simultaneous activation of multiple locus coeruleus efferents. Life Sci 26: 1373–1378

    PubMed  Google Scholar 

  • Done CJ, Sharp T (1994) Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat. Neuropharmacology 33: 411–421

    PubMed  Google Scholar 

  • Feuerstein TJ, Hertting G (1986) Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS. Naunyn Schmiedebergs Arch Pharmacol 333: 191–197

    PubMed  Google Scholar 

  • Fuller RW (1994) Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci 55: 163–167

    PubMed  Google Scholar 

  • Fuller RW, Perry KW (1989) Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats. J Pharmacol Exp Ther 248: 50–56

    PubMed  Google Scholar 

  • Gariepy KC, Bailey B, Yu J, Maher T, Ackworth IN (1994) Simultaneous determination of norepinephrine, dopamine, and serotonin in hippocampal microdialysis samples using normal bore high performance liquid chromatography: effects of dopamine receptor agonist stimulation and euthanasia. J Liquid Chromatogr 17: 1541–1556

    Google Scholar 

  • Goldfarb J, Walcott J, Blandina P (1993) Serotonergic modulation of L-glutamic acidevoked release of endogenous norepinephrine from rat hypothalamus. J Pharmacol Exp Ther 267: 45–50

    PubMed  Google Scholar 

  • Hemrick-Luecke SK, Snoddy HD, Fuller RW (1994) Evaluation of nefazodone as a serotonin uptake inhibitor and serotonin antagonist in vivo. Life Sci 55: 479–483

    PubMed  Google Scholar 

  • Herve D, Pickel VM, Joh TH, Beaudet A (1987) Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435: 71–83

    PubMed  Google Scholar 

  • Hjorth S, Carlsson A (1986) Is pindolol a mixed agonist-antagonist at central serotonin(5-HT) receptors? Eur J Pharmacol 129: 131

    PubMed  Google Scholar 

  • Jordan S, Kramer GL, Zukas PK, Moeller M, Petty F (1994) In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse 18: 294–297

    PubMed  Google Scholar 

  • Leger L, Descarries L (1978) Serotonin nerve terminals in the locus coeruleus of adult rat: a radioautographic study. Brain Res 145: 1–13

    PubMed  Google Scholar 

  • Mayle DA, Robertson DW, Wong DT (1991) Elevation of catecholaminergic metabolite levels in the rat hypothalamus by an agonist of serotonin 1C/2 receptors, MK212 (6-chloro-2-(l-piperazinyl) pyrazine). Neurosci Abstr 17: 407

    Google Scholar 

  • McRae-Degueurce A, Dennis T, Leger L, Scatton B (1985) Regulation of noradrenergic neuronal activity in the rat locus coeruleus by serotonergic afferents. Physiol Psychol 13: 188–196

    Google Scholar 

  • Mongeau R, De Montigny C, Blier P (1994) Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures. Eur J Pharmacol 256: 269–279

    PubMed  Google Scholar 

  • Paez X, Leibowitz S (1993) Changes in extracellular PVN monoamines and macronutrient intake after idazoxan or fluoxetine injection. Pharm Biochem Behav 46: 933–941

    Google Scholar 

  • Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, San Diego CA

    Google Scholar 

  • Perry KW, Fuller RW (1991) Serotonergic drugs increase MHPG-SO4 in rat hypothalamus. Neurosci Abstr 17: 1178

    Google Scholar 

  • Perry KW, Fuller RW (1992) Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci 50: 1683–1690

    PubMed  Google Scholar 

  • Pickel VM, Joh TH, Chan J, Beaudet A (1984) Serotonergic terminals: ultrastuctural and synaptic interaction with catecholamine-containing neurons in the medial nuclei of the solitary tracts. J Comp Neurol 225: 291–301

    PubMed  Google Scholar 

  • Pozzi L, Invernizzi R, Cervi L, Vallebuona F, Samanin R (1994) Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J Neurochem 63: 195–200

    PubMed  Google Scholar 

  • Rutter JJ, Auerbach SB (1993) Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J Pharmacol Exp Ther 265: 1319–1324

    PubMed  Google Scholar 

  • Sabol SE, Richards JB, Sciden LS (1992) Fenfluramine-induced increases in extracellular hippocampal serotonin are progressively attenuated in vivo during a four-day fenfluramine regimen in rats. Brain Res 571: 64–72

    PubMed  Google Scholar 

  • Scatton B, Claustre Y, Graham D, Dennis T, Serrano A, Arbilla S, Pimoule C, Schoemaker H, Bigg D, Langer SZ (1988) SL 81 0385: a novel selective and potent serotonin uptake inhibitor. Drug Dev Res 12: 29–40

    Google Scholar 

  • Smythe GA, Gleeson RM, Stead BM (1988) Mechanisms of 5-hydroxy-L-tryptophaninduced adrenocorticotropin release: a major role for central noradrenergic drive. Neuroendocrinology 47: 389–397

    PubMed  Google Scholar 

  • Suzuki M, Matsuda T, Asano S, Somboonthum P, Takuma K, Baba A (1995) Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine(la) receptor activation. Br J Pharmacol 115: 703–711

    PubMed  Google Scholar 

  • Tanda G, Carboni E, Frau R, Di Chiara G (1994) Increase in extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology 115: 285–288

    PubMed  Google Scholar 

  • Tian Y, Eaton MJ, Goudreau JL, Lookingland KJ, Moore KE (1993) Neurochemical evidence that 5-hydroxytryptaminergic neurons tonically inhibit noradrenergic neurons terminating in the hypothalamus. Brain Res 607: 215–221

    PubMed  Google Scholar 

  • Weissmann-Nanopoulos D, Mach E, Magre J, Demassey Y, Pujo J (1985) Evidence for the localization of 5HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem Int 7: 1061–1072

    Google Scholar 

  • Wong DT, Bymaster FP, Reid LR, Threlkeld PG (1983) Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors. Biochem Pharmacol 32: 1287–1293

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. K. W. Perry

    Present address: Central Nervous System Research, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA

Authors and Affiliations

  1. Central Nervous System Research, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA

    R. W. Fuller

Authors
  1. K. W. Perry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. W. Fuller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perry, K.W., Fuller, R.W. Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats. J. Neural Transmission 104, 953–966 (1997). https://doi.org/10.1007/BF01285563

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01285563

Keywords

Search

Navigation